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Background: Metabolic flexibility described as “the capacity of the body to match fuel oxidation to fuel availability”
has been implicated in insulin resistance. We examined fasting substrate oxidation in relation to dietary
macronutrient intake, and markers of insulin resistance in otherwise healthy women, with and without a family
history of diabetes mellitus (FH DM).
Methods: We measured body composition (dual x-ray absorptiometry), visceral and subcutaneous adipose tissue
area (VAT, SAT, using Computerised Tomography), fasting [glucose], [insulin], [free fatty acids], [blood lipids], insulin
resistance (HOMA-IR), resting energy expenditure (REE), respiratory exchange ratio(RER) and self-reported physical
activity in a convenience sample of 180 women (18-45 yrs). A food frequency questionnaire was used to assess
energy intake (EI) and calculate the RER: Food Quotient (FQ) ratio. Only those with EI:REE (1.05 -2.28) were included
(N=140). Insulin resistance was defined HOMA-IR (>1.95).
Results: The Insulin Resistant (IR) group had higher energy, carbohydrate and protein intakes (p < 0.05) and lower
PA levels than Insulin Sensitive (IS) group (P < 0.001), but there were no differences in RER or RER:FQ between
groups. However, nearly 50% of the variance in HOMA-IR was explained by age, body fat %, VAT, RER:FQ and FH
DM (adjusted R2 = 0.50, p < 0.0001). Insulin-resistant women, and those with FH DM had a higher RER:FQ than their
counterparts (p < 0.01), independent of body fat % or distribution.
Conclusion: In these apparently healthy, weight-stable women, insulin resistance and FH DM were associated with
lower fat oxidation in relation to dietary fat intake, suggesting lower metabolic flexibility.
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The World Health Organization estimates that nearly
60% of adult cases of diabetes, 1 in 5 cases of ischemic
heart diseases, and between 8-42% of certain cancers
may be attributable to adult obesity [1]. Obesity and dia-
betes have become major public health problems in both
developed and developing countries [2-4]. This trend in
obesity may be linked to changes in population levels of
physical activity [5], along with a changing food* Correspondence: vicki.lambert@uct.ac.za
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reproduction in any medium, provided the orenvironment, in which low cost, high energy density,
high-fat foods are more freely available [6-8].
Consumption of energy dense/high fat diets is strongly
and positively associated with overweight and insulin re-
sistance, particularly when the excess body fat is located
in abdominal region [9,10]. Nevertheless, the link be-
tween fat intake and overweight is not limited to the
high-energy content of fatty foods, but has also been
shown to be associated with a reduced capacity to
oxidize dietary fat [11-14].
Metabolic flexibility has been defined as “a clear cap-
acity to utilize lipid and carbohydrate fuels and to transi-
tion between them” in response to changes in dietary
energy intake or circulating substrate concentrationsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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only the obese state, but to the metabolic sequelae of in-
sulin resistance [16]. Metabolic flexibility as an ‘intrinsic
property of skeletal muscle’ has been further supported
by in vitro studies in which the capacity of glucose to
suppress fat oxidation in cultured myotubes from muscle
biopsy samples was inversely correlated with in vivo in-
sulin sensitivity and positively correlated to % body fat
and serum free fatty acid levels [17].
Metabolic flexibility in vivo is typically measured by
quantifying the oxidative response to some metabolic
challenge, such as insulin-stimulation [18] or short-term,
high-fat feeding. For example, in a study [19], young,
otherwise healthy men, with a family history of diabetes,
had a lower fat oxidation in response to a 3-day, high-fat
diet, when compared to the fat oxidation those without
a family history of diabetes.
Evidence from epidemiological [20,21] and interven-
tion studies, implicates total dietary fat, and in particular,
dietary saturated fat in insulin resistance. The potential
mechanisms underpinning the effect of dietary fatty
acids on insulin resistance may include altered substrate
oxidation and metabolic flexibility [22], modifications in
the composition of cell membranes, and stimulation of
pro-inflammatory pathways in the body, promoting
chronic inflammation, and may be associated with
increased risk for cancer, heart disease, stroke, diabetes,
arthritis and auto-immunity [10].
In this study, we propose a pragmatic measure of
metabolic flexibility by comparing fasting substrate oxi-
dation, with habitual dietary macronutrient intake, for
the purposes of screening. This measure may provide
some potential targets for intervention, for the purposes
of preventing Type 2 diabetes mellitus [23].
Therefore, we firstly hypothesized that the measure of
fasting fat oxidation in relation to habitual dietary fat
and fatty acid intake, as a proxy for metabolic flexibility,
would be associated with obesity and insulin resistance
in a group of apparently healthy women. We further
hypothesized, that this relationship may be modulated
by a family history of diabetes. Thus, the findings of the
present study support the notion that interventions to
improve metabolic flexibility, and thereby insulin sensi-
tivity, should ideally target physical activity levels, and/or
dietary fat content or quality.
Methods
Subjects
A convenience sample of 180 healthy premenopausal
urban-dwelling white South African women between the
ages of 18 to 45 years was recruited through the local
media, as part of a larger study [24]. The protocol was
approved by the Research Ethics Committee of the Fac-
ulty of Health Sciences, University of Cape Town. Thestudy was explained to each participant prior to the start
of the trial and informed, written consent was obtained
from all subjects.
Body composition
Body weight was measured, using a combination scale
and stadiometer (Universal weight enterprise Detecto
model BW-150, Taipei, Taiwan). Waist girth (at the level
of the umbilicus) and hip girth (over the area of largest
circumference) were measured in participants with a
steel anthropometric tape (Rosscraft Innovations Incor-
porated, Canada) wearing light clothing and were also
used to calculate the waist-to-hip ratio (WHR). Whole
body composition was measured using dual-energy
X-ray absorptiometer (DXA) (Hologic QDR 4500
Discovery-W with software version 4.40, Hologic Inc.,
Bedford, MA, USA) according to standard procedures.
The co-efficient of variation (%) for fat-free mass, using
this technique, is as low as 0.7%, and 1.67% for fat mass.
Body fat distribution was measured using computerized
tomography (CT) scans at the level of the L4-L5 lumbar
vertebrae. Visceral and subcutaneous tissue areas (VAT
and SAT, respectively) were quantified as described pre-
viously [25]. Due to logistical constraints DXA scans
were only completed on 66 insulin sensitive and 70 insu-
lin resistant subjects and CT scans on 55 insulin sensi-
tive and 58 insulin resistant subjects.
Blood pressure, glucose tolerance and lipoprotein profiles
Blood pressure (BP, mmHg) was taken as the average of
three readings from the left arm, after subjects rested
quietly for 5 min, using an automated BP device
(OMRON, Kyoto, Japan). Following an over-night fast
(12-h), venous blood samples were collected for the
measurement of plasma concentrations of free fatty
acids (FFA, mmol/l), total-cholesterol (TC, mmol/l),
HDL-cholesterol, mmol/l, LDL-cholesterol, mmol/l, tri-
glycerides, mmol/l, glucose, mmol/l, and insulin, mU/l.
Fasting plasma glucose concentration were analysed
using the glucose oxidase method (YSI 2300 STAT
PLUS; YSI Life Sciences, Yellow Springs, OH, USA),
and blood lipids were measured using the Roche
modular autoanalyzer and enzymatic colorimetric
assays were used to analyze total cholesterol, triglycer-
ides, and HDL-C concentrations. The LDL-C concen-
trations were determined using the Friedewald
formula [26]. Insulin levels were determined by a
Micro particle Enzyme Immunoassay (MEIA) (AxSym
Insulin Kit, Abbott, IL, USA).
Insulin sensitivity
The homeostasis model assessment (HOMA) of insulin
resistance was calculated from fasting glucose and insu-
lin levels [27]. A cut-off point of 1.95 for HOMA-IR was
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lin sensitive (IS), > 1.95 for insulin resistant (IR) groups
[28].
Habitual energy and nutrient intake
All participants completed a previously validated, struc-
tured food frequency [29] questionnaire (Dietary Assess-
ment and Education Kit, Medical Research Council of
South Africa, South Africa) administered by a registered
dietician. Energy intake (EI) was analysed using the com-
puter package FoodFinder™3 software application (Ver-
sion 1, Medical Research Council of South Africa). Total
energy intake (TEI) (kJ), total carbohydrate (CHO), pro-
tein, fat and alcohol (g and % of energy) were calculated.
The food quotient (FQ) was calculated from the food
records, with the macronutrient composition expressed
in percentage, using the following equations:
FQ ¼ 0:207 carbohydrate %ð Þ þ 0:159 fat %ð Þ
þ0:193 protein %ð Þ
þ0:137 alcohol %ð ÞÞ=0:207
carbohydrate %ð Þ
þ0:226 fat %ð Þ þ 0:243 protein %ð Þ
þ0:206 alcohol %ð ÞÞ
[30].
Excluding under/over reporters, only subjects with an
EI: REE ≥ 1.05 and < 2.28, ie. adequate reporters, were
included in this analysis [31]. Of the 140 included in the
final sample, 69 were insulin sensitive, and 71 insulin re-
sistant. The following reported dietary variables were
also documented: carbohydrates, fats (poly & mono-
unsaturated and saturated fats) and protein (animal and
plant).
Short fat questionnaire (SFQ)
The short fat questionnaire [32] is a brief, 17-item self-
administered questionnaire which provides a measure of
habitual dietary fat consumption. Fifteen of the ques-
tions are worth 0 to 4 points, whereas the remaining
two can yield a maximum of 2 points each. Finally, the
scores of all items are summed to generate a total out of
64 which is interpreted as follows: 0–17 = low fat intake;
18–39 = moderate fat intake; ≥ 40 = high fat intake.
Resting energy expenditure (REE), respiratory exchange
ratio (RER) and metabolic flexibility measured by RER:FQ
ratio
Resting energy expenditure (REE) was measured using
indirect calorimetry (Sensor Medics VMAX ventilated
hood indirect calorimeter, Yorba Linda, CA) following a
12-h overnight fast. Subjects were instructed to report to
the laboratory very early in the morning and rested in
the supine position for 20-min. Subjects were tested in adarkened, thermo-neutral room and instructed to refrain
from any movement for the duration of the assessment.
The measurement period was 30 min, to allow time to
reach and maintain a metabolic steady state.
Respiratory exchange rate (RER) and energy expend-
iture (EE) were averaged from the last 10 min of each as-
sessment. Energy expenditure was converted into
kilojoules using the Weir equation [33], and expressed
on a per minute basis. The estimated fat and carbohy-
drate oxidation rates were calculated using the average
respiratory exchange ratio (RER). The proxy measure for
metabolic flexibility in the present study was the fasting
RER:FQ ratio. A value of greater than 1, suggested that
fat oxidation was lower relative to the fat intake in the
diet.
Demographic, medical history, socio-cultural and
behavioural factors
Subjects completed a demographic questionnaire, deter-
mining socio-economic status on the basis of factors
such as: education, housing and housing density and oc-
cupation. Physical activity was self-reported and assessed
using the previously validated Global Physical Activity
Questionnaire (GPAQ) [34].
In addition, subjects reported personal and family
medical history and were subsequently grouped accord-
ing to family history of obesity (FH OB) and family his-
tory of diabetes mellitus (FH DM), on the basis of one
or more of their immediate family members having the
condition.
Statistics
The data were analyzed using Statistica Version 9 (Stats-
Soft Inc. Version 8, Tulsa, OK, USA) and expressed as
means and standard deviations. Data that were not nor-
mally distributed were log-transformed where necessary.
The insulin sensitive women were significantly older
than the insulin resistant women. Therefore, all analyses
were subsequently age-adjusted. Insulin sensitive and in-
sulin resistant groups were compared, with respect to
anthropometry, dietary intake and reported energy ex-
penditure and metabolic outcomes, using analyses of co-
variance. Combining the two groups (Insulin sensitive
and Insulin resistant), pearson-product moment correla-
tions were used to identify variables that were associated
with RER and HOMA-IR. Multiple regression analysis
was used to determine factors that were independently
associated with insulin resistance in our study sample in-
cluding age, metabolic flexibility, body composition, diet
and physical activity. HOMA-IR was log-transformed for
the analysis.
Analyses of covariance were subsequently used to
compare insulin-resistant and insulin-sensitive groups,
with respect to RER, dietary intake, and physical activity
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family history diabetes mellitus (FH DM), adjusting for
age and body composition. An alpha level of less than or
equal to 0.05 was accepted as statistically significant.Results
Subject characteristics
The subject characteristics of the study population are
presented in Table 1. The insulin sensitive group was
younger and more physically active than the insulin re-
sistant group (p < 0.001). The insulin resistant group had
a higher body fat %, waist circumference (cm), VAT
(cm2) and SAT (cm2). However, the insulin sensitive
group had a higher VAT/SAT ratio (p < 0.001).Metabolic risk parameters
Fasting plasma [glucose], and serum [insulin], and
HOMA-IR, presented in Table 2, were significantly
higher in the IR group, by design. [Total cholesterol],
[LDL-chol], [triglycerides], and TC/HDL ratio were also
significantly higher in the IR group compared to the IS
group (even after adjusting for age).Habitual dietary intake
The habitual reported dietary intake of both groups is
presented in Table 3. Total reported energy intake (MJ/
day) (p < 0.05), and dietary fat (g) intake were signifi-
cantly higher in the insulin resistant group, compared to
the insulin sensitive group. Further, saturated fat (% of
total energy), mono-and poly-unsaturated fat % (% of
total energy) and ω-6 fatty acids (g) were also signifi-
cantly higher in the insulin resistant group (p < 0.05, data
not shown). In contrast, there was no significant differ-
ence in the food quotient between groups.Table 1 Subject characteristics and body composition
IS N IR N P value
Age (years) 31±7.6 69 31±8.6 71 <0.001
Weight (kg) 61±6.4 69 91.6±15 71 <0.0001
BMI(kg/m2) 21.5±1.8 69 33±4.8 71 <0.0001
Waist (cm) 76.8±6.4 69 103±11.1 71 <0.0001
Body fat (%) 27.9±5.02 66 43±5.3 70 <0.0001
VAT (cm2) 61.2±20.1 55 141.9±61 58 <0.0001
SAT (cm2) 165±62.5 55 487±142.5 58 < 0.0001
VAT/SAT 0.41±0.2 55 0.30±0.11 58 <0.001
MET.min/wk 308±357 69 152±205 71 <0.05
FH obesity (%) 18(26%) 69 26(36.6%) 71 0.07
FH DM (%) 10(14.4%) 69 19(26.76%) 71 <0.05
Results from analysis of covariance, ANCOVA, values are adjusted for age and
expressed as means ± SD. BMI, body mass index; VAT, visceral adipose tissue;
SAT, subcutaneous adipose tissue, FH, Family History; DM, Diabetes Mellitus.Resting energy expenditure and substrate oxidation
Unadjusted resting energy expenditure values were sig-
nificantly lower in the insulin resistant group (p < 0.001,
Table 3). However following adjustment for free fat
mass, resting energy expenditure between groups was
not different. Similarly we found no differences in the
RER and RER: FQ ratio between groups.
Factors associated with substrate oxidation (RER), insulin
resistance (HOMA-IR) and metabolic flexibility (RER:FQ)
When combining the groups (Table 4), we showed that
certain lifestyle variables (lower fat oxidation higher re-
spiratory exchange ratio, lower RER:FQ ratio) and body
composition (higher body fat %, and subcutaneous adi-
pose tissue, higher visceral adipose tissue and waist cir-
cumference) were associated with HOMA-IR. We also
found significant inverse associations between specific ω-3
dietary fatty acids, eicosapentaenoic acid (C20:5; EPA,
r=−0.22, P < 0.009), docosapentaenoic acid (C22:5, DPA,
r=−0.27, P < 0.001), docosahexaenoic acid (C22:6; DHA,
r=−0.29, P < 0.0001), and resting energy expenditure. A
higher habitual intake of these dietary fatty acids was
associated with an overall higher rate of fasting fat
oxidation. In addition, RER:FQ ratio was significantly
correlated to other markers of metabolic risk includ-
ing [HDL-C] (r = − 0.19, P = 0.03), and [TG/HDL]
ratio, (r = 0.19, P = 0.03).
We subsequently performed a multiple regression ana-
lysis to determine factors that were independently asso-
ciated with insulin resistance (Table 5). Age, free fatty
acids, METS, visceral adipose tissue and total body fat
(%), family history of diabetes, as well as RER:FQ,
accounted for 50% of variance in HOMA-IR (log trans-
formed) (p < 0.00001).
Furthermore, subjects who had a HOMA ≥ 1.95 had a
higher RER:FQ ratio, as well as a higher resting energy
expenditure than those with HOMA < 1.95 (p < 0.006),
even after adjusting for differences in body fat % and
age. Similarly, those with a family history of diabetes also
had a higher RER:FQ ratio, after adjusting for differences
in body fat percentage and age (p < 0.05) (Figure 1).
Discussion
The results of the present study supported our hypoth-
esis that metabolic inflexibility, indicated by a pragmatic
proxy measure of fasting resting energy expenditure to
food quotient (RER:FQ) ratio, was associated with insu-
lin resistance and family history of diabetes mellitus, in
otherwise apparently healthy women, independent of
body fatness and age. Insulin resistance was associated
with lower rates of whole body fat oxidation in relation
to habitual dietary fat intake. This extends the findings
of Ukropcova [19], who demonstrated impaired meta-
bolic flexibility in response to short-term high-fat
Table 2 Markers of metabolic risk between IS and IR groups
IS N IR N P value
Fasting [glucose] (mmol/l) 4.5 ± 0.3 69 4.8 ± 0.4 71 <0.0001
[Insulin] (mU/l) 4.8 ± 1.3 69 12.7 ± 4.7 71 0.01
[FFA] (mmol/l) 0.33 ± 0.2 69 0.31 ± 0.2 70 NS
HOMA-IR 0.98 ± 0.3 69 2.71 ± 1.1 71 <0.0001
Total [cholesterol] (mmol/l) 4.6 ± 0.8 69 4.9 ± 1.0 71 0.033
[LDL-C] (mmol/l) 2.5 ± 0.8 69 3.0 ± 0.85 71 <0.0001
[HDL-C] (mmol/l) 1.8 ± 0.4 69 1.5 ± 0.4 71 <0.0001
[Triglycerides] (mmol/l) 0.90 ±0.4 69 1.17 ± 0.6 71 <0.0001
TC/HDL 2.6 ± 0.7 69 3.5 ± 1.1 71 <0.0001
TG/HDL 0.5 ± 0.26 67 0.86 ± 0.6 71 <0.0001
Results from ANCOVA, values are adjusted for age and expressed as the means ± SD.
FFA, free fatty acids; HOMA-IR,homeostasis model for insulin resistance; LDL-C.
low-density lipoprotein-cholesterol,HDL-C,high-density lipoprotein-cholesterol.
TG, triglycerides.
Table 4 Dietary and lifestyle factors associated with
HOMA-IR
N r P value
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in resting energy expenditure during sleep or in response
to a hyperinsulinaemic, euglycaemic clamp. Similar to
the current study, this effect was most marked in those
with a family history of Type 2 diabetes mellitus. How-
ever, unlike previous studies, the present study demon-
strated these relationships using simple fasted resting
measures of substrate oxidation, against self-reported,
habitual dietary fat intake, without any manipulation of
diet, or induced glycaemia [16].
The link between substrate oxidation or metabolic
flexibility and family membership, as well as, family his-
tory of diabetes, has been demonstrated using 24-hr
resting energy expenditure [14,30], fasting substrate oxi-
dation [34] and suppression of fat oxidation in response
to insulin-induced glycaemia and in response to high-fat
feeding, Ukropcova [17,19], hypothesized that patterns
of fat oxidation are genetically or epigenetically deter-
mined, in that, the differences in metabolic phenotype
were independent of body fat percentage. TakenTable 3 Habitual dietary Intake, energy expenditure and
substrate oxidation
IS IR P value
(N=69) (N=71)
Energy and macronutrient intake
Energy Intake (MJ/d) 9.1±1.9 9.7±1.9 <0.05
Carbohydrate (g) 238.2±62.7 263.1±66.4 0.02
Protein (g) 80.2±19.4 131.2±17.9 0.04
Fat Intake (g) 75.2±23.4 79.6 ±24.2 <0.05
Food Quotient (FQ) 0.86±0.02 0.86±0.02 NS
Energy expenditure and substrate oxidation
RER 0.87±0.1 0.89±0.1 NS
RER/FQ 1.01±0.1 1.03±0.1 NS
Results of ANCOVA, values are expressed as the means ± SD; MJ/day, mega
joules per day; RER, respiratory exchange ratio; FQ, food quotient.together, these results suggest that metabolic inflexibility
is linked to genetic or epigenetic phenomenon, and is
not secondary to insulin resistance, or the result of obes-
ity, per se.
In previous studies, metabolic inflexibility has been
shown to be concomitant with reduced skeletal muscle
mitochondria size and density, [17,35] with an associated
decrease in capacity for complete oxidative disposal of
fat and loss of insulin sensitivity. Meex, [36] demon-
strated that, 3 months of exercise training improved
insulin sensitivity in both type 2 diabetics and non-
diabetic individuals, along with metabolic flexibility, par-
ticularly in relation to insulin-stimulated, oxidative, glu-
cose disposal. In addition, mitochondrial function was
increased in both groups. This is consistent with theAdded Sugar (g) 140 0.20 0.005
% Total Energy(Sugar) 140 0.20 0.008
Insoluble fibre (g) 140 −0.25 0.003
Soluble fibre (g) 140 −0.26 0.002
ω-6 FA (g) 140 0.21 0.01
% Energy Plant Protein 140 −0.23 0.006
Physical activity (MET. min/week) 140 −0.29 0.001
Short Fat Questionnaire (pts) 140 0.28 0.001
RER 140 0.21 0.01
RER/FQ 140 −0.19 0.03
Body Fat % 136 0.56 0.0001
Total SAT (cm2) 113 0.60 0.0001
VAT (cm2) 113 0.54 0.0001
VAT/SAT 113 −0.20 0.02
Waist (cm) 140 0.60 0.0001
Results of Pearson-product moment correlations.
Table 5 Forward, stepwise, multiple linear regression for log HOMA-IR
Partial correlation coefficients Β Parameter estimates Std Error P value
Intercept −1.06 0.29 0.0005
Age (years) −0.31 −0.010 0.003 0.0002
%Body Fat 0.41 0.012 0.003 0.0001
VAT 0.32 0.00137 0.0005 0.005
RER/FQ 0.23 0.839 0.260 0.002
FH DM 0.16 0.0975 0.435 0.027
[FFA] −0.15 −0.206 0.097 0.035
Physical activity (MET. min/week) −0.08 −0.00008 0.00007 0.24
VAT, visceral adipose tissue; RQ, respiratory quotient; FH DM, family history of diabetes mellitus, FFA, free fatty acids, Adjusted R2 =0.50, SEE = 0.18, P < 0.00001.
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activity levels and RER:FQ ratio contributed to the over-
all variance in HOMA-IR, or insulin resistance (Table 5).
However, we found no direct correlation between self-
reported physical activity and resting energy expenditure
or the RER:FQ ratio. The lack of a direct association be-
tween physical activity, fasting substrate oxidation and
metabolic flexibility, as measured in the present study,
may be related to the fact physical activity levels were
generally low, and the data were not normally distribu-
ted. Alternatively subjects may have over reported phys-
ical activity levels or the GPAQ may not have been
sufficiently sensitive to distinguish between groups. Not
unexpectedly, we found that the insulin resistant group
reported lower levels of physical activity and a higher
dietary fat intake [37], and thus, may have additionally
confounded this relationship in bivariate analyses.
One unexpected finding in the present study, was the
inverse associations between serum free fatty acids con-
centrations and insulin resistance, in these non-diabetic,
otherwise healthy women. While there are numerous
studies that have shown that elevated free-fatty acid
levels may be implicated in the aetiology of insulin re-
sistance and are associated with Type 2 diabetes mellitusFigure 1 Fat oxidation in relation to dietary fat was lower
(represented by a higher RER/FQ ratio) in persons with a family
history of diabetes, and in those who were insulin resistant.[37,38], there is also some indication that the sequelae of
insulin resistance may be tissue- and substrate-specific
[16,39]. As such, it is possible that in these non-diabetic
subjects, the increased circulating insulin concentra-
tions, were still effective in the suppression of lipolysis
or in the non-oxidative disposal of fatty acids [40].
In a cohort study, Bickerton, [41] compared men in the
highest and lowest quartiles for fasting plasma insulin and
found that there were no differences between groups with
respect to circulating free fatty acid concentrations. How-
ever, those with the highest fasting insulin also had higher
triglyceride concentrations. In a smaller metabolic study,
insulin-resistant men were compared to weight-matched,
BMI-matched controls. Despite higher insulin levels, the
insulin-resistant group had similar fasting free fatty acid
concentrations when compared to control subjects, and
systemic fatty acid production and appearance were lower.
These authors suggest that there are ‘altered metabolic
partitioning’ of fatty acids (reduced oxidation, increased
re-esterification), in response to the insulin resistant state.
This is consistent with Forbes [42], who found that lipoly-
sis, palmitate appearance and palmitate oxidation were
actually lower in non-obese women at risk for diabetes
compared to controls. While at the same time, they
demonstrated higher plasma insulin levels, suggesting
increased capacity for storing fat.
The influence of diet on insulin sensitivity is mediated
by both energy and nutrient content, in particular by dif-
ferent types of dietary fatty acids [42,43]. The higher
dietary fat intake (Table 3) of the insulin resistant group
compared to the insulin sensitive group directly relates
to insulin sensitivity [44]. We also found that higher
dietary ω-3 fatty acids, specifically C20:5, C22:5, and
C22:6, were strongly associated with increased fat oxida-
tion (data not shown). Thus, specific dietary fatty acids
may modulate the relationship between substrate oxida-
tion and insulin resistance, by altering fatty acid parti-
tioning, towards either storage or oxidation [45].
One limitation of the present study was that total
fat intake was assessed by a quantified validated food
frequency questionnaire (FFQ) [29], rather than an
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potential for bias, as over and under reporters were
excluded from the analysis. However, a study in a
sample of American men comparing fatty acid intake
assessed by subcutaneous fat aspirate [46], 2-weeks
diet records, and an amended version of the food
frequency questionnaire used in the US Nurses’
Health Study [47] suggested that the estimates of fat
intake from the food frequency questionnaire were as
valid as those from the diet records.
Conclusion
We found that a pragmatic measure of metabolic flexi-
bility based on fasting respiratory exchange ratio in rela-
tion to reported habitual dietary fat intake was a useful
marker of insulin resistance in otherwise, healthy
women, independent of obesity. Importantly, metabolic
flexibility, measured in this way, was lower in those
women who reported a family history of diabetes melli-
tus. Further research is needed to characterize the oxida-
tive response to various dynamic challenges to better
clarify the role of metabolic flexibility in the patho-
physiology of obesity and diabetes. Additionally, longitu-
dinal studies, monitoring changes in substrate oxidation
in relation to substrate balance, over time, and in rela-
tion to changes in body energy stores and fat distribu-
tion are needed. Finally, there is a need for a greater
understanding of the respective role of genotype and en-
vironment in determining this susceptible phenotype.Competing interests
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